Alps Advisors Inc Forma Therapeutics Holdings, Inc. Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $15,749 - $44,770	-2,212 Reduced 7.8%	26,147 $522,000
Q2 2022 Aug 11, 2022	SELL	$5.1 - $10.0 $104,193 - $204,300	-20,430 Reduced 41.87%	28,359 $195,000
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $50,590 - $89,109	-6,066 Reduced 11.06%	48,789 $454,000
Q4 2021 Feb 09, 2022	SELL	$13.6 - $24.89 $85,557 - $156,582	-6,291 Reduced 10.29%	54,855 $780,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $26,525 - $32,125	-1,250 Reduced 2.0%	61,146 $1.42 Million

Q2 2021 Aug 11, 2021	SELL	$22.86 - $30.95 $391,637 - $530,235	-17,132 Reduced 21.54%	62,396 $1.55 Million
Q1 2021 May 07, 2021	BUY	$24.58 - $42.82 $125,972 - $219,452	5,125 Added 6.89%	79,528 $2.23 Million
Q4 2020 Feb 03, 2021	BUY	$34.9 - $51.08 $2.6 Million - $3.8 Million	74,403 New	74,403 $2.6 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.